HCAT Health Catalyst, Inc.
Nasdaq · SEC CIK 1636422 · EDGAR
- Bought, last 12 months
- $105.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $200.6K 2 sales by 2 insiders
- Filings on record
- 343 since 2021-07-06, latest 2026-09-16 16:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Larson-Green Julie | Dir | — | $128.2K |
| Kohl Simeon | CEO, Dir | $105.4K | — |
| Landry Benjamin | GC | — | $72.4K |
| Albert Benjamin | CEO, Dir | — | — |
| Hoggard Green Jill | Dir | — | — |
| Freeman Kevin Lee | Chief Commercial Off | — | — |
| Alger Jason | CFO | — | — |
| Burton Daniel D. | CEO, Dir | — | — |
| Gallagher Duncan | Dir | — | — |
| Llewelyn Linda | CHRO | — | — |
Transactions 414
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-03 | 2024-12-01 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +2,001 | 78.9K | +3% | $0 | |
| 2024-12-03 | 2024-12-01 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +1,616 | 68.8K | +2% | $0 | |
| 2024-12-03 | 2024-12-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $8.97 | -30.9K | 1.13M | -3% | -$277.1K | |
| 2024-12-03 | 2024-12-01 | HCAT | Pramoda Anita | Dir | A - Grant | $0.00 | +1,847 | 58.2K | +3% | $0 | |
| 2024-12-03 | 2024-12-01 | HCAT | Alger Jason | CFO | F - Tax | $8.97 | -7,795 | 106.3K | -7% | -$69.9K | |
| 2024-12-03 | 2024-12-01 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $8.97 | -11.4K | 244.4K | -4% | -$102.5K | |
| 2024-12-03 | 2024-12-02 | HCAT | Freeman Kevin Lee | Chief Commercial Off | S - Sale | $8.94 | -7,500 | 236.9K | -3% | -$67.0K | |
| 2024-12-03 | 2024-12-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $8.97 | -7,766 | 105.1K | -7% | -$69.7K | |
| 2024-12-03 | 2024-12-01 | HCAT | LeSueur Daniel | COO | F - Tax | $8.97 | -10.5K | 119.2K | -8% | -$93.8K | |
| 2024-12-03 | 2024-12-01 | HCAT | Landry Benjamin | GC | F - Tax | $8.97 | -9,419 | 91.5K | -9% | -$84.5K | |
| T | 2024-11-18 | 2024-11-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $8.50 | -1,365 | 112.9K | -1% | -$11.6K |
| T | 2024-11-07 | 2024-11-05 | HCAT | LeSueur Daniel | COO | S - Sale | $7.70 | -5,209 | 129.7K | -4% | -$40.1K |
| T | 2024-10-17 | 2024-10-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $8.16 | -1,324 | 114.3K | -1% | -$10.8K |
| T | 2024-10-08 | 2024-10-03 | HCAT | LeSueur Daniel | COO | S - Sale | $7.68 | -5,209 | 134.9K | -4% | -$40.0K |
| T | 2024-09-18 | 2024-09-16 | HCAT | Llewelyn Linda | CHRO | S - Sale | $8.43 | -1,324 | 115.6K | -1% | -$11.2K |
| 2024-09-10 | 2024-09-01 | HCAT | Pramoda Anita | Dir | A - Grant | $0.00 | +2,228 | 56.3K | +4% | $0 | |
| 2024-09-10 | 2024-09-01 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +1,950 | 67.2K | +3% | $0 | |
| T | 2024-09-10 | 2024-09-06 | HCAT | Landry Benjamin | GC | S - Sale | $7.39 | -2,466 | 100.9K | -2% | -$18.2K |
| T | 2024-09-10 | 2024-09-06 | HCAT | Alger Jason | CFO | S - Sale | $7.39 | -2,899 | 114.1K | -2% | -$21.4K |
| 2024-09-10 | 2024-09-01 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +2,414 | 76.9K | +3% | $0 | |
| 2024-09-05 | 2024-09-03 | HCAT | Llewelyn Linda | CHRO | F - Tax | $7.27 | -1,613 | 116.9K | -1% | -$11.7K | |
| 2024-09-05 | 2024-09-03 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $7.27 | -2,772 | 263.4K | -1% | -$20.2K | |
| 2024-09-05 | 2024-09-03 | HCAT | Freeman Kevin Lee | Chief Commercial Off | S - Sale | $7.22 | -7,500 | 255.9K | -3% | -$54.1K | |
| 2024-09-05 | 2024-09-03 | HCAT | LeSueur Daniel | COO | F - Tax | $7.27 | -1,761 | 148.2K | -1% | -$12.8K | |
| 2024-09-05 | 2024-09-04 | HCAT | LeSueur Daniel | COO | S - Sale | $7.58 | -8,137 | 140.1K | -5% | -$61.7K | |
| 2024-09-05 | 2024-09-03 | HCAT | Alger Jason | CFO | F - Tax | $7.27 | -1,165 | 117.0K | -1.0% | -$8,470 | |
| 2024-09-05 | 2024-09-03 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $7.27 | -4,174 | 1.16M | -0.4% | -$30.3K | |
| 2024-09-05 | 2024-09-03 | HCAT | Landry Benjamin | GC | F - Tax | $7.27 | -1,222 | 103.4K | -1% | -$8,884 | |
| T | 2024-08-16 | 2024-08-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $6.57 | -1,328 | 118.5K | -1% | -$8,725 |
| T | 2024-08-07 | 2024-08-05 | HCAT | LeSueur Daniel | COO | S - Sale | $6.19 | -5,209 | 150.0K | -3% | -$32.2K |
| T | 2024-07-17 | 2024-07-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $6.51 | -1,290 | 119.9K | -1% | -$8,398 |
| T | 2024-07-08 | 2024-07-03 | HCAT | LeSueur Daniel | COO | S - Sale | $6.15 | -5,208 | 155.2K | -3% | -$32.0K |
| T | 2024-06-20 | 2024-06-17 | HCAT | Llewelyn Linda | CHRO | S - Sale | $6.37 | -1,290 | 121.2K | -1% | -$8,217 |
| 2024-06-17 | 2024-06-13 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +20.8K | 65.2K | +47% | $0 | |
| 2024-06-17 | 2024-06-13 | HCAT | Pramoda Anita | Dir | A - Grant | $0.00 | +20.8K | 54.1K | +63% | $0 | |
| 2024-06-17 | 2024-06-13 | HCAT | Smith S. Dawn | Dir | A - Grant | $0.00 | +20.8K | 65.5K | +47% | $0 | |
| 2024-06-17 | 2024-06-13 | HCAT | KANE JOHN A | Dir | A - Grant | $0.00 | +20.8K | 131.0K | +19% | $0 | |
| 2024-06-17 | 2024-06-13 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +20.8K | 74.5K | +39% | $0 | |
| T | 2024-06-14 | 2024-06-12 | HCAT | Alger Jason | CFO | S - Sale | $6.83 | -2,823 | 118.2K | -2% | -$19.3K |
| T | 2024-06-12 | 2024-06-06 | HCAT | Landry Benjamin | GC | S - Sale | $6.71 | -2,387 | 104.6K | -2% | -$16.0K |
| T | 2024-06-12 | 2024-06-11 | HCAT | Freeman Kevin Lee | Chief Commercial Off | S - Sale | $6.53 | -7,500 | 266.2K | -3% | -$49.0K |
| T | 2024-06-12 | 2024-06-06 | HCAT | LeSueur Daniel | COO | S - Sale | $6.72 | -11.9K | 160.4K | -7% | -$80.1K |
| 2024-06-04 | 2024-06-03 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $6.53 | -2,951 | 273.7K | -1% | -$19.3K | |
| 2024-06-04 | 2024-06-03 | HCAT | Llewelyn Linda | CHRO | F - Tax | $6.53 | -1,716 | 122.4K | -1% | -$11.2K | |
| 2024-06-04 | 2024-06-03 | HCAT | Alger Jason | CFO | F - Tax | $6.53 | -1,238 | 121.0K | -1% | -$8,084 | |
| 2024-06-04 | 2024-06-03 | HCAT | LeSueur Daniel | COO | F - Tax | $6.53 | -1,873 | 172.3K | -1% | -$12.2K | |
| 2024-06-04 | 2024-06-03 | HCAT | Landry Benjamin | GC | F - Tax | $6.53 | -1,300 | 107.0K | -1% | -$8,489 | |
| 2024-06-04 | 2024-05-31 | HCAT | Landry Benjamin | GC | S - Sale | $6.61 | -12.6K | 108.3K | -10% | -$83.1K | |
| 2024-06-04 | 2024-06-03 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $6.53 | -4,442 | 1.16M | -0.4% | -$29.0K | |
| T | 2024-05-20 | 2024-05-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $7.00 | -2,066 | 124.2K | -2% | -$14.5K |
| T | 2024-04-17 | 2024-04-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $6.11 | -2,005 | 126.2K | -2% | -$12.3K |
| T | 2024-03-19 | 2024-03-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $7.80 | -2,005 | 128.2K | -2% | -$15.6K |
| 2024-03-05 | 2024-03-01 | HCAT | Alger Jason | CFO | F - Tax | $8.05 | -2,474 | 52.2K | -5% | -$19.9K | |
| 2024-03-05 | 2024-03-01 | HCAT | Alger Jason | CFO | A - Grant | $0.00 | +70.0K | 122.2K | +134% | $0 | |
| 2024-03-05 | 2024-03-01 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $8.05 | -4,540 | 276.6K | -2% | -$36.5K | |
| 2024-03-05 | 2024-03-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $8.05 | -3,439 | 130.2K | -3% | -$27.7K | |
| 2024-03-05 | 2024-03-01 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $8.05 | -11.7K | 219.8K | -5% | -$94.1K | |
| 2024-03-05 | 2024-03-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $8.05 | -4,973 | 1.17M | -0.4% | -$40.0K | |
| 2024-03-05 | 2024-03-01 | HCAT | Landry Benjamin | GC | F - Tax | $8.05 | -3,315 | 120.9K | -3% | -$26.7K | |
| 2024-03-05 | 2024-03-01 | HCAT | LeSueur Daniel | COO | F - Tax | $8.05 | -3,279 | 104.2K | -3% | -$26.4K | |
| 2024-03-05 | 2024-03-01 | HCAT | LeSueur Daniel | COO | A - Grant | $0.00 | +70.0K | 174.2K | +67% | $0 | |
| 2024-02-27 | 2024-02-27 | HCAT | Burton Daniel D. | CEO, Dir | P - Purchase | $7.81 | +26.2K | 1.17M | +2% | +$204.6K | |
| M | 2024-02-22 | 2024-02-20 | HCAT | Llewelyn Linda | CHRO | A - Grant | $0.00 | +68.9K | 129.8K | +113% | $0 |
| M | 2024-02-22 | 2024-02-20 | HCAT | Landry Benjamin | GC | A - Grant | $0.00 | +79.4K | 119.8K | +197% | $0 |
| 2024-02-22 | 2024-02-20 | HCAT | Burton Daniel D. | CEO, Dir | A - Grant | $0.00 | +250.0K | 1.15M | +28% | $0 | |
| M | 2024-02-22 | 2024-02-20 | HCAT | Freeman Kevin Lee | Chief Commercial Off | A - Grant | $0.00 | +113.3K | 281.1K | +68% | $0 |
| 2024-02-22 | 2024-02-20 | HCAT | Hunt Bryan Truman | CFO | A - Grant | $0.00 | +11.1K | 231.5K | +5% | $0 | |
| 2024-02-22 | 2024-02-20 | HCAT | Alger Jason | CAO | A - Grant | $0.00 | +2,778 | 54.7K | +5% | $0 | |
| T | 2024-02-20 | 2024-02-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $9.77 | -3,262 | 64.8K | -5% | -$31.9K |
| T | 2024-01-18 | 2024-01-16 | HCAT | Llewelyn Linda | CHRO | S - Sale | $10.83 | -3,163 | 68.0K | -4% | -$34.3K |
| T | 2023-12-19 | 2023-12-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $8.83 | -3,163 | 71.2K | -4% | -$27.9K |
| T | 2023-12-07 | 2023-12-06 | HCAT | Alger Jason | CAO | S - Sale | $7.55 | -2,177 | 51.9K | -4% | -$16.4K |
| 2023-12-05 | 2023-12-01 | HCAT | Landry Benjamin | GC | F - Tax | $7.45 | -3,427 | 44.8K | -7% | -$25.5K | |
| 2023-12-05 | 2023-12-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $7.45 | -4,161 | 74.4K | -5% | -$31.0K | |
| 2023-12-05 | 2023-12-01 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $7.45 | -2,921 | 167.8K | -2% | -$21.8K | |
| 2023-12-05 | 2023-12-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $7.45 | -8,478 | 896.4K | -0.9% | -$63.2K | |
| 2023-12-05 | 2023-12-01 | HCAT | Bickmore Anne Marie | COO, Chief Product Off | F - Tax | $7.45 | -4,114 | 63.7K | -6% | -$30.6K | |
| 2023-12-05 | 2023-12-01 | HCAT | Alger Jason | CAO | F - Tax | $7.45 | -2,838 | 54.1K | -5% | -$21.1K | |
| 2023-12-05 | 2023-12-01 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $7.45 | -14.1K | 220.4K | -6% | -$105.2K | |
| T | 2023-11-17 | 2023-11-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $8.25 | -1,196 | 78.5K | -2% | -$9,867 |
| T | 2023-10-20 | 2023-10-16 | HCAT | Llewelyn Linda | CHRO | S - Sale | $8.33 | -1,161 | 79.7K | -1% | -$9,671 |
| 2023-10-06 | 2023-10-05 | HCAT | Landry Benjamin | GC | A - Grant | $0.00 | +20.0K | 48.2K | +71% | $0 | |
| T | 2023-09-19 | 2023-09-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $11.01 | -1,160 | 80.9K | -1% | -$12.8K |
| 2023-09-06 | 2023-09-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $11.78 | -1,484 | 82.1K | -2% | -$17.5K | |
| 2023-09-06 | 2023-09-01 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $11.78 | -4,128 | 234.5K | -2% | -$48.6K | |
| 2023-09-06 | 2023-09-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $11.78 | -7,103 | 904.9K | -0.8% | -$83.7K | |
| 2023-09-06 | 2023-09-06 | HCAT | Alger Jason | CAO | S - Sale | $11.65 | -2,197 | 56.9K | -4% | -$25.6K | |
| 2023-09-06 | 2023-09-01 | HCAT | Alger Jason | CAO | F - Tax | $11.78 | -929 | 59.1K | -2% | -$10.9K | |
| 2023-09-06 | 2023-09-01 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $11.78 | -8,460 | 170.7K | -5% | -$99.7K | |
| 2023-09-06 | 2023-09-01 | HCAT | Bickmore Anne Marie | COO, Chief Product Off | F - Tax | $11.78 | -1,682 | 67.8K | -2% | -$19.8K | |
| 2023-09-06 | 2023-09-01 | HCAT | Landry Benjamin | GC | F - Tax | $11.78 | -500 | 29.3K | -2% | -$5,890 | |
| 2023-09-06 | 2023-09-06 | HCAT | Landry Benjamin | GC | S - Sale | $11.52 | -1,157 | 28.2K | -4% | -$13.3K | |
| T | 2023-08-24 | 2023-08-22 | HCAT | Llewelyn Linda | CHRO | S - Sale | $11.90 | -737 | 83.5K | -0.9% | -$8,770 |
| T | 2023-07-11 | 2023-07-07 | HCAT | Landry Benjamin | GC | S - Sale | $11.14 | -1,179 | 29.8K | -4% | -$13.1K |
| M | 2023-06-16 | 2023-06-14 | HCAT | Smith S. Dawn | Dir | A - Grant | $0.00 | +17.9K | 44.7K | +67% | $0 |
| M | 2023-06-16 | 2023-06-14 | HCAT | Pramoda Anita | Dir | A - Grant | $0.00 | +18.3K | 33.3K | +122% | $0 |
| M | 2023-06-16 | 2023-06-14 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +17.6K | 44.4K | +66% | $0 |
| M | 2023-06-16 | 2023-06-14 | HCAT | TEMPLETON MARK B | Dir | A - Grant | $0.00 | +17.9K | 26.9K | +199% | $0 |
| M | 2023-06-16 | 2023-06-14 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +18.3K | 53.7K | +52% | $0 |
| M | 2023-06-16 | 2023-06-14 | HCAT | KANE JOHN A | Dir | A - Grant | $0.00 | +22.6K | 110.2K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations